There are other reasons that help explain the growing use of synthetic data in training AI models. Some things are so scarce or rare that they are barely represented in real data. Rather than letting ...

ASML Holding stock has seen its consensus analyst price target rise slightly, moving from €941.90 to €949.81. This change comes amid growing optimism among equity analysts, with many pointing to the ...

MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Qualtrics report reveals widening competitive gap as AI-first research teams capture significantly more budget and strategic ...

Surveys, focus groups, test visits and stakeholder meetings also informed their inspection decisions. Leaders’ union NAHT is ...

UK, representing its health and care membership, has submitted evidence to NHS England’s consultation on the 10-Year Health ...

Abeona Therapeutics is at a critical juncture, trading near 52-week lows ahead of its first ZEVASKYN revenue update in Q3.

Key findings Item non-response rates: o Overall rates were within ideal levels (below 5%) for all items except for perceived abortion prevalence (12.2%). o Average rates across the 11 items were also ...